Significant blood sugar improvement with Xultophy® 100/3.6 compared to insulin reported
Xultophy® 100/3.6 (insulin degludec and liraglutide injection) 100 units/mL and 3.6 mg/mL provided superior A1C reduction compared to insulin glargine U-100 when used as an add-on to a SGLT-2i (an oral diabetes medication), according to results from the DUAL IX study. June 23, 2018